Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis
Open Access
- 24 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (4), 703-708
- https://doi.org/10.1093/jac/dki284
Abstract
Objectives: Pharmacokinetic (PK)/pharmacodynamic (PD) models have become increasingly important in optimizing antimicrobial therapy. This approach is highly recommended by regulatory authorities intending to force the evaluation of antimicrobial action at the site of infection. Methods: Clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus with MICs of 4, 8 and 16 mg/L for piperacillin were used in an in vivo PK/in vitro PD model. Bacteria were exposed in vitro to the concentration-versus-time profiles of piperacillin in plasma and subcutaneous adipose tissue measured in vivo in septic patients. Samples were withdrawn at defined intervals and the numbers of bacteria per mL were counted and plotted against time. Results: Piperacillin levels determined in plasma were able to effectively inhibit bacterial growth of all bacterial strains used in the present study (MIC ranged from 4–16 mg/L). In contrast, concentration-versus-time profiles of subcutaneous adipose tissue were effective in killing isolates with MICs of 4 and 8 mg/L only, while bacterial growth of S. aureus and P. aeruginosa with MICs of 16 mg/L was not inhibited. Conclusions: Bacteria with MICs < 16 mg/L were effectively inhibited in subcutaneous adipose tissue in patients with sepsis. The prediction of microbiological outcome based on concentrations of piperacillin in plasma resulted in a marked overestimation of antimicrobial activity at the site of infection.This publication has 19 references indexed in Scilit:
- Resistance in the environmentJournal of Antimicrobial Chemotherapy, 2004
- Relevance of Soft-Tissue Penetration by Levofloxacin for Target Site Bacterial Killing in Patients with SepsisAntimicrobial Agents and Chemotherapy, 2003
- Target site penetration of fosfomycin in critically ill patientsJournal of Antimicrobial Chemotherapy, 2003
- Closed-Chest Microdialysis to Measure Antibiotic Penetration into Human Lung TissueAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Does the Dose Matter?Clinical Infectious Diseases, 2001
- Impaired target site penetration of β -lactams may account for therapeutic failure in patients with septic shockCritical Care Medicine, 2001
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- Pharmacokinetics of Drugs Used in Critically Ill AdultsClinical Pharmacokinetics, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- The ACCP-SCCM Consensus Conference on Sepsis and Organ FailureSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1992